healthcare
IDFC Alternatives invests $20m in Medi Assist
IDFC Alternatives has committed INR1.25 billion ($20.39 million) to Medi Assist, a Bangalore-based health benefits manager.
KKR to invest about $150 million in India's Gland Pharma – report
KKR is reported to be in the process of buying around 30% of Gland Pharma, an active pharmaceutical ingredients and injectable drugs manufacturer, for $150 million.
Singapore's DCP leads $20m Series B for Amaranth Medical
DCP Management has led the $20 million Series B round of funding for Amaranth Medical, a medical device manufacturer. Existing investors Bio*One Capital, Charter Life Sciences and Phillip Capital, as well as new entrant Venstar Capital, also participated.
Panasonic unit gets KKR cure
KKR's acquisition of Panasonic Healthcare marks a return to form for the firm after its earlier efforts to acquire Japanese chipmaker Renesas were frustrated by the government-backed Innovation Network Corporation of Japan (INCJ). The deal had raised...
VC-backed Value HR sees shares double after $8.5m Japan IPO
VC-backed Value HR, a Japanese human resources benefits service provider, saw its stock more than double in value to JPY4035 ($41.5) on its trading debut in Tokyo on Friday.
KKR acquires Panasonic healthcare unit for $1.67b
KKR has agreed to acquire an 80% stake in Panasonic Healthcare, a unit of the Japanese electronics giant, for JPY165 billion ($1.67 billion) - the buyout firm's biggest deal in the country to date.
Abraaj exits Philippines hospital DMMC
The Abraaj Group has made a full exit from Daniel O. Mercado Medical Center (DMMC), a tertiary care hospital based in the Philippines. The exit is said to have been through a buy-back arrangement with the Mercado family.
Warburg Pincus invests in China health center Amcare
Warburg Pincus has invested in Beijing-based Amcare Women's & Children's Hospital. The transaction size was not disclosed.
KKR considers teaming with Japan state fund for Panasonic unit - report
KKR may partner with a Japanese state-backed investment fund in a bid to secure a stake in Panasonic's healthcare unit.
WuXi PharmaTech-backed Foundation Medicine sets terms for $75m IPO
US cancer diagnostics firm Foundation Medicine, which counts the corporate venture fund of Shanghai-headquarted WuXi PharmaTech among its backers, has announced the terms for its US IPO.
Sequoia leads Series B round in China menstruation-tracking app
Sequoia Capital China has led a Series B round of founding for Dayima.com, a menstruation cycle-tracking mobile app. Existing backer Bertelsmann Asia Investments also participated in the round.
Affordable healthcare chain Glocal gets $4m from SIDBI VC
SIDBI Venture Capital has invested INR250 million ($3.93 million) in Glocal Healthcare Systems, which operates multi-specialty hospitals in semi-rural parts of East India.
TPG invests $23m in Sutures India
TPG Growth has acquired a minority stake in Bangalore-based surgical equipment maker Sutures India for INR1.45 billion ($22.9 million).
Shanghai Sinopharm PE invests in chemical firm Anhui Fulltime
Sinopharm Capital, a private equity arm of Chinese drug distributing conglomerate Sinopharm, has made a pre-IPO investment in chemical products manufacturer Anhui Fulltime Specialized Solvent & Reagent.
Orion Partners to launch $250m Japan care homes fund
Hong Kong-headquartered Orion Partners, formerly known as Ajia Partners, is looking to raise as much as JPY25 billion ($250 million) for its third Japan care homes investment fund.
Morgan Stanley PE Asia makes partial exit from Sihuan Pharma
Morgan Stanley Private Equity Asia (MSPEA) will make a partial exit from Hong Kong-listed Sihuan Pharmaceutical Holdings, joining company management in selling a 6.8% stake via a block trade agreement.
Standard Chartered PE raises stake in Fortis Healthcare
Standard Chartered Private Equity (SCPE) has invested a further INR370.3 million ($5.7 million) to buy preferential shares in India’s Fortis Healthcare. It brings SCPE’s total investment into the company to approximately INR2.5 billion.
Matrix India commits $6m to Meditrina Hospitals
Matrix Partners India has invested INR400 million ($6 million) in Kerala-based Meditrina Hospitals for a significant minority stake. The private equity firm is the sole participant in the first round of investment.
Quadria reaches first close on South, Southeast Asia healthcare fund
Quadria Capital has reached a first close of $107 million on its second fund, which invests in mid-size healthcare companies in South and Southeast Asia. This is the first vehicle the GP has raised independently, its predecessor being the Milestone Religare...
China’s BVCF targets super bacteria
“Large pharmaceutical firms aren’t putting a lot of resources into developing antibiotics nowadays because they can make more money producing drugs for chronic-related diseases, or cancer treatments,” observes Zhi Yang, founder and managing partner...
Carlyle, Cathay Capital, PingAn jointly invest in Meinian Onehealth
A consortium, comprising The Carlyle Group, Cathay Capital Private Equity and China Ping An Insurance, has agreed to invest RMB300 million ($49 million) in Meinian Onehealth Healthcare Group, the largest private provider of preventive healthcare check-up...
China Everbright’s private markets business sees profit spike
China Everbright's private market business - which includes a variety of PE, VC and sector funds - generated a pre-tax profit of HK$205 million ($26.4 million) in the first half of 2013, up 17% year-on-year.
Simcere accepts Hony-backed take-private bid worth $490m
Chinese drug developer Simcere Pharmaceutical Group has agreed to a management buyout offer from a consortium led by its chairman and Hony Capital that values the company at approximately $490 million. Simcere is now expected to de-list from the New York...
Baird Capital invests in China's Kedu Healthcare
Baird Capital, the private investment arm of Robert W. Baird & Co, has invested in Kedu Healthcare, one of China's largest independent medical equipment service providers.